Novartis’ Exclusivity Covenants. On a Product-by-Product and Exclusive Target-by-Exclusive Target basis, Novartis and its Affiliates will not (independently or with a Third Party):
Appears in 5 contracts
Samples: Option and License Agreement, Strategic Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc), Option and License Agreement (Akcea Therapeutics, Inc.)
